Possible involvement of multiple cytochrome P450S in fentanyl and sufentanil metabolism as opposed to alfentanil. (Q51540970)

6 April 2018

title

Possible involvement of multiple cytochrome P450S in fentanyl and sufentanil metabolism as opposed to alfentanil. (English)

1 reference

6 April 2018

0 references

6

1 reference

6 April 2018

author name string

Guitton J

1

1 reference

6 April 2018

Buronfosse T

2

1 reference

6 April 2018

Désage M

3

1 reference

6 April 2018

Lepape A

4

1 reference

6 April 2018

Brazier JL

5

1 reference

6 April 2018

language of work or name

English

0 references

publication date

1 June 1997

1 reference

6 April 2018

published in

Biochemical Pharmacology

1 reference

6 April 2018

volume

53

1 reference

6 April 2018

issue

11

1 reference

6 April 2018

page(s)

1613-1619

1 reference

6 April 2018

Clinical pharmacokinetics of fentanyl and its newer derivatives.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900893-3

Is the metabolism of alfentanil subject to debrisoquine polymorphism? A study using human liver microsomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900893-3

In vitro inhibition of a polymorphic human liver P-450 isozyme by narcotic analgesics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900893-3

Human alfentanil metabolism by cytochrome P450 3A3/4. An explanation for the interindividual variability in alfentanil clearance?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900893-3

Identification of the pharmacogenetic determinants of alfentanil metabolism: cytochrome P-450 3A4. An explanation of the variable elimination clearance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900893-3

Lack of bimodality in nifedipine plasma kinetics in a large population of healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900893-3

Influence of Dexmedetomidine and Clonidine on Human Liver Microsomal Alfentanil Metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900893-3

Propofol inhibits enzymatic degradation of alfentanil and sufentanil by isolated liver microsomes in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900893-3

Pharmacokinetic interaction of propofol and fentanyl: single bolus injection study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900893-3

Comparison of urinary 6-beta-cortisol and the erythromycin breath test as measures of hepatic P450IIIA (CYP3A) activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900893-3

In vitro systems for prediction of rates of drug clearance and drug interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900893-3

Development and preliminary application of a high-performance liquid chromatographic assay for omeprazole metabolism in human liver microsomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900893-3

Cytochrome P-450 monooxygenase activities in human and rat liver microsomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900893-3

Determination of protein: A modification of the lowry method that gives a linear photometric response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900893-3

Metabolism of fentanyl in isolated hepatocytes from rat and guinea pig.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900893-3

Isolation and characterization of a cytochrome P450 of the IIA subfamily from human liver microsomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900893-3

Capillary gas chromatographic-mass spectrometric method for the identification and quantification of some benzodiazepines and their unconjugated metabolites in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900893-3

Human-liver cytochromes P-450 expressed in yeast as tools for reactive-metabolite formation studies. Oxidative activation of tienilic acid by cytochromes P-450 2C9 and 2C10

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900893-3

Human cytochromes P450 expressed in Escherichia coli: production of specific antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900893-3

The erythromycin breath test predicts the clearance of midazolam.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900893-3

Species differences and interindividual variation in liver microsomal cytochrome P450 2A enzymes: effects on coumarin, dicumarol, and testosterone oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900893-3

DNA-expressed human cytochrome P450s: a new age of molecular toxicology and human risk assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900893-3

Biochemistry and molecular biology of the human CYP2C subfamily

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900893-3

Evolution of a highly polymorphic human cytochrome P450 gene cluster: CYP2D6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900893-3

Pharmacokinetics of sufentanil in general surgical patients under different conditions of anaesthesia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900893-3

Unconsciousness associated with midazolam and erythromycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900893-3

Cyclosporin toxicity at therapeutic blood levels and cytochrome P-450 IIIA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900893-3

Comparative pharmacokinetics of fentanyl and alfentanil.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900893-3

Linearity of pharmacokinetics and model estimation of sufentanil.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900893-3

Prolonged alfentanil effect following erythromycin administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900893-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Alfentanil pharmacokinetics in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2896%2900893-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-2952(96)00893-3

1 reference

6 April 2018

1 reference

6 April 2018